Literature DB >> 10201930

Expression of murine IL-12 is regulated by translational control of the p35 subunit.

J M Babik1, E Adams, Y Tone, P J Fairchild, M Tone, H Waldmann.   

Abstract

IL-12 is a heterodimer of two subunits, p35 and p40, encoded by separate genes that are regulated independently. To investigate the mechanisms underlying the regulation of the p35 gene, we characterized murine p35 expression in the B cell lymphoma line A20 and in bone marrow-derived dendritic cells. Multiple transcription start sites were identified in both cell types, resulting in four p35 mRNA isoforms (types I-IV) that differ in the number and position of upstream ATGs in their 5' untranslated regions. In nonstimulated cells, the predominant forms of p35 message (types II and IV) contained an additional upstream ATG, whose presence was shown to inhibit the downstream translation of the p35 subunit. After LPS stimulation, however, transcription initiated from alternate positions, so that the proportion of transcripts not containing this upstream ATG (types I and III) was significantly increased in the population of p35 mRNA. These type I and type III transcripts readily supported translation of the p35 subunit and its incorporation into bioactive IL-12. Furthermore, p35 mRNA levels were substantially up-regulated after LPS stimulation in both cell types. Thus, our results show that p35 gene expression is highly regulated by both transcriptional and translational mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201930

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Constraints on reinitiation of translation in mammals.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

Review 2.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

3.  Regulation of lipopolysaccharide-induced interleukin-12 production by activation of repressor element GA-12 through hyperactivation of the ERK pathway.

Authors:  Shinji Saito; Motohiro Matsuura; Yoshikazu Hirai
Journal:  Clin Vaccine Immunol       Date:  2006-08

Review 4.  New insights into IL-12-mediated tumor suppression.

Authors:  S Tugues; S H Burkhard; I Ohs; M Vrohlings; K Nussbaum; J Vom Berg; P Kulig; B Becher
Journal:  Cell Death Differ       Date:  2014-09-05       Impact factor: 15.828

5.  The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages.

Authors:  A W Taylor
Journal:  J Neuroimmunol       Date:  2005-05       Impact factor: 3.478

Review 6.  Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.

Authors:  Lin Sun; Chang He; Lekha Nair; Justine Yeung; Charles E Egwuagu
Journal:  Cytokine       Date:  2015-03-18       Impact factor: 3.861

7.  Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei.

Authors:  G C Ulett; N Ketheesan; R G Hirst
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Regulation of translation by upstream translation initiation codons of surfactant protein A1 splice variants.

Authors:  Nikolaos Tsotakos; Patricia Silveyra; Zhenwu Lin; Neal Thomas; Mudit Vaid; Joanna Floros
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-17       Impact factor: 5.464

Review 9.  Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans.

Authors:  Lyudmila Lyakh; Giorgio Trinchieri; Lisa Provezza; Giuseppe Carra; Franca Gerosa
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

10.  Ustekinumab in the therapy of chronic plaque psoriasis.

Authors:  Jenna L O'Neill; Robert E Kalb
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.